Mary F. Brunette, MD | Psychiatrist.com

Original Research

Olanzapine Plus Samidorphan in Schizophrenia With AUD

March 10, 2020

Alcohol use disorder is comorbid in 33% of US patients with schizophrenia. Testing the tolerability of olanzapine and samidorphan until the first event of exacerbation of disease symptoms is...

Mary F. Brunette, Christoph U. Correll, Stephanie S. O' Malley, et al

Original Research

Long-Acting Injectable vs Oral Risperidone for Schizophrenia and Co-Occurring Alcohol Use Disorder: A Randomized Trial

August 18, 2015

Alan I. Green, Mary F. Brunette, Ree Dawson, et al

Original Research

The RAISE: First-Episode Psychosis

March 25, 2015

Read an article describing The RAISE Early Treatment Program for First-Episode Psychosis, the background and study design of the program.

John M. Kane, Nina R. Schooler, Patricia Marcy, et al

Article

Psychosocial Interventions for the Long-Term Management of Patients With Severe Mental Illness and Co-Occurring Substance Use Disorder

July 14, 2006

Mary F. Brunette, Kim T. Mueser

Letter to the Editor

Reply to "Prescribing Benzodiazepines for Patients With Substance Use Disorders"

November 1, 2004

Robin E. Clark, Haiyi Xie, Mary F. Brunette

Original Research

Benzodiazepine Prescription Practices and Substance Abuse in Persons With Severe Mental Illness

February 1, 2004

Robin E. Clark, Haiyi Xie, Mary F. Brunette